220 related articles for article (PubMed ID: 1512145)
1. The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence of glutathione depletion by buthionine sulfoximine.
Halperin EC; Brizel DM; Honore G; Sontag MR; Griffith OW; Bigner DD; Friedman HS
Int J Radiat Oncol Biol Phys; 1992; 24(1):103-9. PubMed ID: 1512145
[TBL] [Abstract][Full Text] [Related]
2. L-buthionine-sulfoximine-mediated radiosensitization in experimental interstitial radiotherapy of intracerebral D-54 MG glioma xenografts in athymic mice.
Lippitz BE; Halperin EC; Griffith OW; Colvin OM; Honore G; Ostertag CB; Bigner DD; Friedman HS
Neurosurgery; 1990 Feb; 26(2):255-60. PubMed ID: 2308673
[TBL] [Abstract][Full Text] [Related]
3. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
Mitchell JB; Russo A; Biaglow JE; McPherson S
Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
[TBL] [Abstract][Full Text] [Related]
4. The effect of glutathione (GSH) depletion in vivo by buthionine sulfoximine (BSO) on the radiosensitization of SR 2508.
Kramer RA; Soble M; Howes AE; Montoya VP
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1325-9. PubMed ID: 2523885
[TBL] [Abstract][Full Text] [Related]
5. Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts.
Skapek SX; Colvin OM; Griffith OW; Groothuis DR; Colapinto EV; Lee Y; Hilton J; Elion GB; Bigner DD; Friedman HS
Biochem Pharmacol; 1988 Nov; 37(22):4313-7. PubMed ID: 3196356
[TBL] [Abstract][Full Text] [Related]
6. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
Skapek SX; Colvin OM; Griffith OW; Elion GB; Bigner DD; Friedman HS
Cancer Res; 1988 May; 48(10):2764-7. PubMed ID: 3359437
[TBL] [Abstract][Full Text] [Related]
7. Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion.
Friedman HS; Colvin OM; Griffith OW; Lippitz B; Elion GB; Schold SC; Hilton J; Bigner DD
J Natl Cancer Inst; 1989 Apr; 81(7):524-7. PubMed ID: 2921776
[TBL] [Abstract][Full Text] [Related]
8. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
Ono K; Shrieve DC
J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
[TBL] [Abstract][Full Text] [Related]
9. Factors involved in depletion of glutathione from A549 human lung carcinoma cells: implications for radiotherapy.
Biaglow JE; Varnes ME; Epp ER; Clark EP; Astor M
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1221-7. PubMed ID: 6469742
[TBL] [Abstract][Full Text] [Related]
10. Survival of rats bearing advanced intracerebral F 98 tumors after glutathione depletion and microbeam radiation therapy: conclusions from a pilot project.
Schültke E; Bräuer-Krisch E; Blattmann H; Requardt H; Laissue JA; Hildebrandt G
Radiat Oncol; 2018 May; 13(1):89. PubMed ID: 29747666
[TBL] [Abstract][Full Text] [Related]
11. Depletion of intracellular GSH and NPSH by buthionine sulfoximine and diethyl maleate: factors that influence enhancement of aerobic radiation response.
Varnes ME; Biaglow JE; Roizin-Towle L; Hall EJ
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1229-33. PubMed ID: 6469743
[TBL] [Abstract][Full Text] [Related]
12. Effect of L-buthionine sulfoximine on the radiation response of human renal carcinoma cell lines.
Leung SW; Mitchell JB; al-Nabulsi I; Friedman N; Newsome J; Belldegrun A; Kasid U
Cancer; 1993 Apr; 71(7):2276-85. PubMed ID: 8095848
[TBL] [Abstract][Full Text] [Related]
13. The toxic effects, GSH depletion and radiosensitivity by BSO on retinoblastoma.
Yi X; Ding L; Jin Y; Ni C; Wang W
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):393-6. PubMed ID: 8195039
[TBL] [Abstract][Full Text] [Related]
14. Rate of buthionine sulfoximine entry into brain and xenotransplanted human gliomas.
Fekete I; Griffith OW; Schlageter KE; Bigner DD; Friedman HS; Groothuis DR
Cancer Res; 1990 Feb; 50(4):1251-6. PubMed ID: 2297773
[TBL] [Abstract][Full Text] [Related]
15. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
Shrieve DC; Denekamp J; Minchinton AI
Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
[TBL] [Abstract][Full Text] [Related]
16. Depletion of glutathione after gamma irradiation modifies survival.
Saunders EL; Meredith MJ; Eisert DR; Freeman ML
Radiat Res; 1991 Mar; 125(3):267-76. PubMed ID: 2000450
[TBL] [Abstract][Full Text] [Related]
17. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
Shrieve DC; Harris JW
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
[TBL] [Abstract][Full Text] [Related]
18. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
Guichard M; Lespinasse F; Malaise EP
Radiat Res; 1986 Jan; 105(1):115-25. PubMed ID: 3945723
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
Kramer RA; Greene K; Ahmad S; Vistica DT
Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
[TBL] [Abstract][Full Text] [Related]
20. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
Clark EP; Epp ER; Biaglow JE; Morse-Gaudio M; Zachgo E
Radiat Res; 1984 May; 98(2):370-80. PubMed ID: 6539482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]